Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Investigative Ophthalmology & Visual Science|May 4, 2019
Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and HyperpermeabilityShinsuke Nakamura, Tetsuro Noguchi, Yuki Inoue, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 2, 2017
Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular NeovascularizationYuki Inoue, Masamitsu Shimazawa, Shinsuke Nakamura, et al.Scientific Reports|July 18, 2020
Effects of progranulin on the pathological conditions in experimental myocardial infarction modelTakahiro Sasaki, Masamitsu Shimazawa, Hiromitsu Kanamori, et al.Journal of Proteome Research|August 25, 2010
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesisTsutomu Nakagawa, Shunsaku Takeishi, Akihiko Kameyama, et al.Molecular Pharmaceutics|October 20, 2023
Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II MiceAtsushi Imakiire, Hideto Morimoto, Hidehiko Suzuki, et al.Thoracic Cancer|December 28, 2024
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab TherapyNao Kobayashi, Noriaki Sunaga, Masakiyo Yatomi, et al.Internal Medicine (Tokyo, Japan)|December 16, 2015
Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy CaseHisao Imai, Nozomi Matsumura, Yuichi Yamazaki, et al.Respiratory Medicine Case Reports|March 23, 2023
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforationMari Sato, Masakiyo Yatomi, Ikuo Wakamatsu, et al.Breathe (Sheffield, England)|November 7, 2022
A pregnant woman with severe dyspnoeaMio Kanbe, Masakiyo Yatomi, Ikuo Wakamatsu, et al.Cancer Chemotherapy and Pharmacology|August 9, 2015
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutationsTomohito Kuwako, Hisao Imai, Tomomi Masuda, et al.Pageof 4